Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

Trial Profile

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2017

At a glance

  • Drugs Influenza A virus vaccine H7N9 Hualan Biological Bacterin (Primary)
  • Indications Influenza A virus H7N9 subtype
  • Focus Adverse reactions
  • Sponsors Hualan Biological Bacterin
  • Most Recent Events

    • 03 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top